UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

In situ normothermic perfusion of livers in controlled circulatory death donation may prevent ischemic cholangiopathy and improve graft survival

American journal of transplantation, 2019-06, Vol.19 (6), p.1745-1758

2019

Volltextzugriff (PDF)

Normothermic Perfusion in the Assessment and Preservation of Declined Livers Before Transplantation: Hyperoxia and Vasoplegia-Important Lessons From the First 12 Cases

Transplantation, 2017-05, Vol.101 (5), p.1084-1098

2017

Volltextzugriff (PDF)

26-hour Storage of a Declined Liver Before Successful Transplantation Using Ex Vivo Normothermic Perfusion

Annals of surgery, 2017-01, Vol.265 (1), p.e1-e2

2017

Volltextzugriff (PDF)

Analysis of ischemia/reperfusion injury in time‐zero biopsies predicts liver allograft outcomes

Liver transplantation, 2015-04, Vol.21 (4), p.487-499

2015

Volltextzugriff (PDF)

Normothermic regional perfusion for donation after circulatory death without prior heparinization

Transplantation, 2014-06, Vol.97 (12), p.1272-1278

2014

Volltextzugriff (PDF)

Cold Pulsatile Machine Perfusion Versus Static Cold Storage for Kidneys Donated After Circulatory Death: A Multicenter Randomized Controlled Trial

Transplantation, 2020-05, Vol.104 (5), p.1019-1025

2020

Volltextzugriff (PDF)

Dual Lactate Clearance in the Viability Assessment of Livers Donated After Circulatory Death With Ex Situ Normothermic Machine Perfusion

Transplantation direct, 2021-12, Vol.7 (12), p.e789-e789

2021

Volltextzugriff (PDF)

Pilot study of a noninvasive real‐time optical backscatter probe in liver transplantation

Transplant international, 2021-04, Vol.34 (4), p.709-720

2021

Volltextzugriff (PDF)

Sildenafil citrate in a donation after circulatory death experimental model of renal ischemia-reperfusion injury

Transplantation, 2014-09, Vol.98 (6), p.612-617

2014

Volltextzugriff (PDF)

Observations on the ex situ perfusion of livers for transplantation

American journal of transplantation, 2018-08, Vol.18 (8), p.2005-2020

2018

Volltextzugriff (PDF)

Beyond Poiseuille: Preservation Fluid Flow in an Experimental Model

Journal of Transplantation, 2013-01, Vol.2013 (2013), p.125-130

2013

Volltextzugriff (PDF)

206 Prospects for Utilisation of Late Outgrowth Endothelial Progenitor Cells as Therapy to Prevent Transplant Vasculopathy

Heart (British Cardiac Society), 2014-06, Vol.100 (Suppl 3), p.A113-A113

2014

Volltextzugriff (PDF)

Functional characterization of late outgrowth endothelial progenitor cells in patients with end‐stage renal failure

Transplant international, 2014-05, Vol.27 (5), p.437-451

2014

Volltextzugriff (PDF)

Differential ABC transporter expression during hematopoiesis contributes to neutrophil-biased toxicity of Aurora kinase inhibitors

Nature communications, 2022-10, Vol.13 (1), p.6021-10, Article 6021

2022

Volltextzugriff (PDF)

Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2020-01, Vol.395 (10220), p.294-303

2020

Volltextzugriff (PDF)

Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010)

Clinical cancer research, 2023-12, Vol.29 (23), p.4751-4759

2023

Volltextzugriff (PDF)

Epidemiology and Management of Pediatric Group A Streptococcal Pneumonia With Parapneumonic Effusion: An Observational Study

The Pediatric infectious disease journal, 2024-09, Vol.43 (9), p.841-850

2024

Volltextzugriff (PDF)

Changes in ABC Transporter Expression during Hematopoiesis Cause Lineage-Biased Cytopenias in Patients Treated with Aurora Kinase Inhibitors

Blood, 2021-11, Vol.138 (Supplement 1), p.4292-4292

2021

Volltextzugriff (PDF)

Results from plasmaMATCH trial cohort E: A phase II trial of olaparib and ceralasertib in patients with triple-negative advanced breast cancer (CRUK/15/010)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.1024-1024

2022

Volltextzugriff (PDF)

Abstract GS3-06: Primary results of the cTRAK TN trial: A clinical trial utilising ctDNA mutation tracking to detect minimal residual disease and trigger intervention in patients with moderate and high risk early stage triple negative breast cancer

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.GS3-06-GS3-06

2022

Volltextzugriff (PDF)

Abstract GS3-06: Results from the plasmaMATCH trial: A multiple parallel cohort, multi-centre clinical trial of circulating tumour DNA testing to direct targeted therapies in patients with advanced breast cancer (CRUK/15/010)

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.GS3-06-GS3-06

2020

Volltextzugriff (PDF)

Working with Olive Cook

Matrix, 2003-12 (23), p.41-49

2003

Volltextzugriff (PDF)

PROGRAMME NEWS

RSA journal, 1995-01, Vol.143 (5456), p.8-18

1995

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

In situ normothermic perfusion of livers in controlled circulatory death donation may prevent ischemic cholangiopathy and improve graft survival

Normothermic Perfusion in the Assessment and Preservation of Declined Livers Before Transplantation: Hyperoxia and Vasoplegia-Important Lessons From the First 12 Cases

26-hour Storage of a Declined Liver Before Successful Transplantation Using Ex Vivo Normothermic Perfusion

Analysis of ischemia/reperfusion injury in time‐zero biopsies predicts liver allograft outcomes

Normothermic regional perfusion for donation after circulatory death without prior heparinization

Cold Pulsatile Machine Perfusion Versus Static Cold Storage for Kidneys Donated After Circulatory Death: A Multicenter Randomized Controlled Trial

Dual Lactate Clearance in the Viability Assessment of Livers Donated After Circulatory Death With Ex Situ Normothermic Machine Perfusion

Pilot study of a noninvasive real‐time optical backscatter probe in liver transplantation

Sildenafil citrate in a donation after circulatory death experimental model of renal ischemia-reperfusion injury

Observations on the ex situ perfusion of livers for transplantation

Beyond Poiseuille: Preservation Fluid Flow in an Experimental Model

Normothermic Machine Perfusion of Donor Livers for Transplantation in the United States – A Randomized Controlled Trial

206 Prospects for Utilisation of Late Outgrowth Endothelial Progenitor Cells as Therapy to Prevent Transplant Vasculopathy

Functional characterization of late outgrowth endothelial progenitor cells in patients with end‐stage renal failure

Differential ABC transporter expression during hematopoiesis contributes to neutrophil-biased toxicity of Aurora kinase inhibitors

Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial

Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial

Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010)

Epidemiology and Management of Pediatric Group A Streptococcal Pneumonia With Parapneumonic Effusion: An Observational Study

Changes in ABC Transporter Expression during Hematopoiesis Cause Lineage-Biased Cytopenias in Patients Treated with Aurora Kinase Inhibitors

Results from plasmaMATCH trial cohort E: A phase II trial of olaparib and ceralasertib in patients with triple-negative advanced breast cancer (CRUK/15/010)

Abstract GS3-06: Primary results of the cTRAK TN trial: A clinical trial utilising ctDNA mutation tracking to detect minimal residual disease and trigger intervention in patients with moderate and high risk early stage triple negative breast cancer

Abstract GS3-06: Results from the plasmaMATCH trial: A multiple parallel cohort, multi-centre clinical trial of circulating tumour DNA testing to direct targeted therapies in patients with advanced breast cancer (CRUK/15/010)

Working with Olive Cook

PROGRAMME NEWS

Suchergebnisse filtern